Unknown

Dataset Information

0

Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders.

ABSTRACT:

SUBMITTER: Gohil VM 

PROVIDER: S-EPMC7855837 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders.

Gohil Vishal M VM  

Expert opinion on investigational drugs 20201105 1

Similar Datasets

Unknown Elesclomol restores mitochondrial function in genetic models of copper deficiency.
| S-EPMC6094114 | biostudies-literature
Unknown Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders.
| S-EPMC8724568 | biostudies-literature
Unknown Elesclomol rescues mitochondrial copper deficiency in disease models without triggering cuproptosis.
| S-EPMC12718110 | biostudies-literature
Unknown FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery.
| S-EPMC10013847 | biostudies-literature
Unknown Oncology Drug Repurposing for Sepsis Treatment.
| S-EPMC9030585 | biostudies-literature
Unknown Drug Repurposing of Metformin for the Treatment of Haloperidol-Related Behavior Disorders and Oxidative Stress: A Preliminary Study.
| S-EPMC10974093 | biostudies-literature
Unknown Network-based drug repurposing for psychiatric disorders using single-cell genomics.
| S-EPMC12648111 | biostudies-literature
Unknown NF-κB Signaling and Inflammation-Drug Repurposing to Treat Inflammatory Disorders?
| S-EPMC8945680 | biostudies-literature
Unknown Drug repurposing for the treatment of glioblastoma multiforme.
| S-EPMC5704391 | biostudies-literature
Unknown An Overview of Investigational and Experimental Drug Treatment Strategies for Marfan Syndrome.
| S-EPMC8366784 | biostudies-literature